HRTS vs. HELX ETF Comparison
Comparison of Tema Cardiovascular and Metabolic ETF (HRTS) to Franklin Genomic Advancements ETF (HELX)
HRTS
Tema Cardiovascular and Metabolic ETF
HRTS Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund advisor generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Grade (RS Rating)
Last Trade
$30.90
Average Daily Volume
14,879
36
HELX
Franklin Genomic Advancements ETF
HELX Description
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovationGrade (RS Rating)
Last Trade
$28.55
Average Daily Volume
2,269
53
Performance
| Period | HRTS | HELX |
|---|---|---|
| 30 Days | -10.02% | -11.42% |
| 60 Days | -11.54% | -13.85% |
| 90 Days | -9.20% | -13.36% |
| 12 Months | 5.29% |
10 Overlapping Holdings
HRTS Overweight 26 Positions Relative to HELX
| Symbol | Grade | Weight | |
|---|---|---|---|
| AMGN | D | 7.97% | |
| CYTK | D | 3.48% | |
| BSX | B | 2.85% | |
| MDT | D | 2.7% | |
| MREO | F | 2.63% | |
| MASI | A | 2.29% | |
| DXCM | C | 2.28% | |
| ASND | F | 2.25% | |
| KROS | C | 2.24% | |
| MIRM | A | 2.23% | |
| MLYS | D | 2.06% | |
| PODD | A | 1.83% | |
| EW | C | 1.81% | |
| ARWR | D | 1.71% | |
| MDGL | C | 1.6% | |
| AKRO | C | 1.4% | |
| WST | C | 1.3% | |
| NVS | D | 1.22% | |
| SLN | F | 1.08% | |
| EWTX | C | 1.01% | |
| NARI | C | 0.96% | |
| VKTX | F | 0.82% | |
| TERN | F | 0.74% | |
| VERV | D | 0.71% | |
| TNYA | D | 0.56% | |
| RANI | D | 0.3% |
HRTS Underweight 43 Positions Relative to HELX
| Symbol | Grade | Weight | |
|---|---|---|---|
| KRYS | D | -4.7% | |
| NTRA | B | -4.64% | |
| MEDP | D | -4.07% | |
| TMO | D | -4.01% | |
| DHR | D | -3.99% | |
| UTHR | B | -2.75% | |
| AZN | F | -2.34% | |
| CDNS | B | -2.34% | |
| CTVA | D | -2.29% | |
| CRL | D | -2.23% | |
| BNTX | D | -2.21% | |
| A | D | -2.11% | |
| INSM | D | -2.08% | |
| RVTY | D | -2.01% | |
| QGEN | D | -1.96% | |
| BRKR | F | -1.94% | |
| SRPT | F | -1.5% | |
| TWST | F | -1.27% | |
| LGND | B | -1.27% | |
| ICLR | F | -1.25% | |
| EXAS | F | -1.2% | |
| LH | B | -1.15% | |
| IQV | F | -1.08% | |
| RGEN | D | -1.08% | |
| BEAM | D | -1.03% | |
| TECH | D | -1.01% | |
| VYGR | F | -0.99% | |
| AZTA | F | -0.95% | |
| NBIX | D | -0.94% | |
| RXRX | F | -0.69% | |
| MRNA | F | -0.66% | |
| BIO | C | -0.59% | |
| VCYT | B | -0.56% | |
| DVAX | C | -0.53% | |
| DOCS | C | -0.51% | |
| CDMO | A | -0.51% | |
| CRSP | D | -0.5% | |
| AVTR | F | -0.46% | |
| BMY | B | -0.36% | |
| BMRN | F | -0.2% | |
| ARE | D | -0.15% | |
| SLP | F | -0.11% | |
| FDMT | F | -0.1% |
HRTS: Top Represented Industries & Keywords
HELX: Top Represented Industries & Keywords
Compare ETFs
